Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / S&P BIOTECH
-
Total 13F shares
-
83,807,625
-
Share change
-
-10,806,946
-
Total reported value
-
$9,381,950,719
-
Put/Call ratio
-
288%
-
Price per share
-
$111.95
-
Number of holders
-
520
-
Value change
-
-$1,103,772,057
-
Number of buys
-
297
-
Number of sells
-
176
Institutional Holders of SPDR SERIES TRUST - S&P BIOTECH (XBI) as of Q2 2020
As of 30 Jun 2020,
SPDR SERIES TRUST - S&P BIOTECH (XBI) was held by
520 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
83,807,625 shares.
The largest 10 holders included
GOLDMAN SACHS GROUP INC, JPMORGAN CHASE & CO, CITIGROUP INC, BNP PARIBAS ARBITRAGE, SA, MORGAN STANLEY, BANK OF AMERICA CORP /DE/, BARCLAYS PLC, HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND, UBS Group AG, and WELLS FARGO & COMPANY/MN.
This page lists
520
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.